NCT00516841 2012-08-23A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerFacet BiotechPhase 2 Terminated16 enrolled
NCT00100685 2012-04-27Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)AbbottPhase 2 Terminated48 enrolled
NCT00369395 2012-04-27A Study of Volociximab in Metastatic MelanomaAbbottPhase 2 Terminated19 enrolled